Duo Effectual Choices for Curing Psoriasis
March 10, 2010 – 9:41 pm | No Comment
A novel study has indicated that in case drug Enbrel failed to show effect in individuals having psoriasis then duo effectual choices, Remicade and Stelara could help provide respite. The latest research outcome indicated that the lately accepted drug Stelara could be beneficial in treating patients having moderate to acute-ranging psoriasis in case Enbrel proved ineffective. Another research  [...]

Read the full story »

Home » Health News

Novel Brain Tumour Research Unravels Potentially Curative Genes

Submitted by Suparna on July 29, 2009 – 12:05 amOne Comment


The most widespread and malevolent form of brain tumours, Gliomas, are pesky trouble mongers characteristically resistant to treatments. The gliomas dispatch tentacles that make the surgical removal of these tumours extremely difficult. Though there might not be any detectable tumour, infinitesimal glioma cells habitually linger, ultimately reproducing, by taking advantage of the immune cells of the brain, the microglial cells for their growth.

Novel Brain Tumour Research Unravels Potentially Curative GenesThe Microglial cells take the aid of sensors like Toll-like receptors to spot any discrepancies in their surroundings owing to brain injury or infectivity. But the point to be noted is these microglial cells instead of launching an assault on the invading glioma cells, they assist in the expansion of the tumour, thus further deteriorating the situation.

Researchers have discovered a group of close to 31 genes that are known to be correlated to glioma brain tumours, inclusive of a crucial one that would be targeted for latest treatments. These net of 31 genes when they undergo particular mutations propel the progress of gliomas in the body.

These genes might not essentially be the sole genes bringing about gliomas, but they give the impression of being the instigators. These set of 31 genes are the linchpin in a potentially systematized transgression net of genes that facilitate the accelerated growth of the tumour. Those individuals with extensive rate of mutations in such genes were seen to have shoddier continued existence in comparison to those with less significant mutation rate.

Another study has revealed that the ANXA7 gene is a fine target to assail during forthcoming treatments to combat the highly common, fast spreading form of glioma, the glioblastoma multiforme or GBM. Those patients with just a single copy of the tumour-repressing ANXA7 gene had poorer rate of survival in comparison to those with the normal two copies.

This latest discovery of the ANXA7 gene will have noteworthy significance in upcoming brain tumor treatments that could shepherd in a revolutionary novel era in cancer study.

Popularity: 1% [?]



Related Health Articles

One Comment »

Leave a comment!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

CommentLuv Enabled